The B.C. Ministry of Health is conducting a survey of patients, caregivers, and advocacy groups to achieve input regarding osteoporosis therapies in British Columbia and B.C. PharmaCare coverage. We know […]
There are many questions for those taking osteoporosis medications and treatments including why they are being prescribed, concerns over side effects and the importance of sticking to a medication schedule. […]
Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]
Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]
Members in action Did you know? ASBMR Osteoporosis Canada will be releasing updated Osteoporosis Management Clinical Guidelines in the fall of 2019. Along with a steering committee, working groups have […]
Tools Algorithm 1 Integrated approach to the management of bone health and fracture prevention in postmenopausal females and males 50 years and older. DOWNLOAD Algorithm 2 Approach to pharmacotherapy to […]
Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]
Strontium ranelate (Protelos) is a drug approved for the treatment of osteoporosis in Europe, but not in Canada. It is effective in reducing fractures . Recently the European Medicines Agency […]
